The spirochete Borrelia recurrentis is the causal agent of louse-borne relapsing fever and is transmitted to humans by the infected body louse Pediculus humanus. We have recently demonstrated that the B. recurrentis surface receptor, HcpA, specifically binds factor H, the regulator of the alternative pathway of complement activation, thereby inhibiting complement mediated bacteriolysis. Here, we show that B. recurrentis spirochetes express another potential outer membrane lipoprotein, termed CihC, and acquire C4b-binding protein (C4bp) and human C1 esterase inhibitor (C1-Inh), the major inhibitors of the classical and lectin pathway of complement activation. A highly homologous receptor for C4bp was also found in the African tick-borne relapsing fever spirochete B. duttonii. Upon its binding to B. recurrentis or recombinant CihC, C4bp retains its functional potential, i.e. facilitating the factor I-mediated degradation of C4b. The additional finding that ectopic expression of CihC in serum sensitive B. burgdorferi significantly increased spirochetal resistance against human complement suggests this receptor to substantially contribute, together with other known strategies, to immune evasion of B. recurrentis.
References
[1]
Houhamdi L, Raoult D (2005) Excretion of living Borrelia recurrentis in feces of infected human body lice. J Infect Dis 191: 1898–1906. doi: 10.1086/429920
Sundnes KO, Haimanot AT (1993) Epidemic of louse-borne relapsing fever in Ethiopia. Lancet 342: 1213–1215. doi: 10.1016/0140-6736(93)92190-5
[4]
Raoult D, Roux V (1999) The body louse as a vector of reemerging human diseases. Clin Infect Dis 29: 888–911. doi: 10.1086/520454
[5]
Cutler SJ (2001) Molecular biology of the relapsing fever borrelia. In: Sussman R, editor. Molecular medical microbiology. Oxford, United Kingdom: Academic Press. pp. 2093–2113.
[6]
Larsson C, Andersson M, Bergstrom S (2009) Current issues in relapsing fever. Curr Opin Infect Dis 22: 443. doi: 10.1097/QCO.0b013e32832fb22b
[7]
Southern PM, Sandford JP (1969) Relapsing fever: a clinical and microbiological review. Med 48: 129–143. doi: 10.1097/00005792-196903000-00002
[8]
Zipfel PF, Skerka C, Hellwage J, Jokiranta ST, Meri S, et al. (2002) Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans 30: 971–978. doi: 10.1042/
[9]
Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6: 132–142. doi: 10.1038/nrmicro1824
[10]
Rossmann E, Kraiczy P, Herzberger P, Skerka C, Kirschfink M, et al. (2007) Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes. J Immunol 178: 7292–7301.
[11]
Grosskinsky S, Schott M, Brenner C, Cutler SJ, Kraiczy P, et al. (2009) Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS ONE 4: e4858. doi: 10.1371/journal.pone.0004858
[12]
Hovis KM, Jones JP, Sadlon T, Raval G, Gordon DL, et al. (2006) Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1. Infect Immun 74: 2007–2014. doi: 10.1128/IAI.74.4.2007-2014.2006
[13]
Hovis KM, McDowell JV, Griffin L, Marconi RT (2004) Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol 186: 2612–2618. doi: 10.1128/JB.186.9.2612-2618.2004
[14]
McDowell JV, Tran E, Hamilton D, Wolfgang J, Miller K, et al. (2003) Analysis of the ability of spirochete species associated with relapsing fever, avian borreliosis, and epizootic bovine abortion to bind factor H and cleave c3b. J Clin Microbiol 41: 3905–3910. doi: 10.1128/JCM.41.8.3905-3910.2003
[15]
Pangburn MK, Schreiber RD, Muller-Eberhard HJ (1977) Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med 146: 257–270. doi: 10.1084/jem.146.1.257
[16]
Kuhn S, Skerka C, Zipfel PF (1995) Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H. J Immunol 155: 5663–5670.
[17]
Meri T, Cutler SJ, Blom AM, Meri S, Jokiranta TS (2006) Relapsing fever spirochetes Borrelia recurrentis and B. duttonii acquire complement regulators C4b-binding protein and factor H. Infect Immun 74: 4157–4163. doi: 10.1128/IAI.00007-06
[18]
Koroleva IV, Sjoholm AG, Schalen C (1998) Binding of complement subcomponent C1q to Streptococcus pyogenes: evidence for interactions with the M5 and FcRA76 proteins. FEMS Immunol Med Microbiol 20: 11–20. doi: 10.1016/S0928-8244(97)00101-6
[19]
Alberti S, Marques G, Camprubi S, Merino S, Tomas JM, et al. (1993) C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun 61: 852–860.
[20]
Fujita T, Matsushita M, Endo Y (2004) The lectin-complement pathway–its role in innate immunity and evolution. Immunol Rev 198: 185–202. doi: 10.1111/j.0105-2896.2004.0123.x
[21]
Gigli I, Fujita T, Nussenzweig V (1979) Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci U S A 76: 6596–6600. doi: 10.1073/pnas.76.12.6596
[22]
Scharfstein J, Ferreira A, Gigli I, Nussenzweig V (1978) Human C4-binding protein. I. Isolation and characterization. J Exp Med 148: 207–222. doi: 10.1084/jem.148.1.207
[23]
Zuckert WR, Lloyd JE, Stewart PE, Rosa PA, Barbour AG (2004) Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi. Infect Immun 72: 1463–1469. doi: 10.1128/IAI.72.3.1463-1469.2004
[24]
Zuckert WR, Meyer J, Barbour AG (1999) Comparative analysis and immunological characterization of the Borrelia Bdr protein family. Infect Immun 67: 3257–3266.
[25]
Dahlback B (1983) Purification of human C4b-binding protein and formation of its complex with vitamin K-dependent protein S. Biochem J 209: 847–856.
[26]
Hartmann K, Corvey C, Skerka C, Kirschfink M, Karas M, et al. (2006) Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61: 1220–1236. doi: 10.1111/j.1365-2958.2006.05318.x
[27]
Lescot M, Audic S, Robert C, Nguyen TT, Blanc G, et al. (2008) The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii. PLoS Genet 4: e1000185. doi: 10.1371/journal.pgen.1000185
[28]
Kramer MD, Schaible UE, Wallich R, Moter SE, Petzoldt D, et al. (1990) Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies. Immunobiology 181: 357–366. doi: 10.1016/S0171-2985(11)80504-8
[29]
Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF (2001) Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur J Immunol 31: 1674–1684. doi: 10.1002/1521-4141(200106)31:6<1674::AID-IMMU1674>3.0.CO;2-2
[30]
Schaible UE, Kramer MD, Eichmann K, Modolell M, Museteanu C, et al. (1990) Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. ProcNatlAcadSciUSA 87: 3768–3772. doi: 10.1073/pnas.87.10.3768
[31]
Wallich R, Brenner C, Kramer MD, Simon MM (1995) Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infection & Immunity 63: 3327–3335.
[32]
Wallich R, Helmes C, Schaible UE, Lobet Y, Moter SE, et al. (1992) Evaluation of genetic divergence among Borrelia burgdorferi isolates by use of OspA, fla, HSP60, and HSP70 gene probes. InfectImmun 60: 4856–4866.
[33]
Kraiczy P, Hellwage J, Skerka C, Becker H, Kirschfink M, et al. (2004) Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279: 2421–2429. doi: 10.1074/jbc.M308343200
[34]
Cutler SJ, Akintunde CO, Moss J, Fukunaga M, Kurtenbach K, et al. (1999) Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis. Int J Syst Bacteriol 49 Pt4: 1793–1799. doi: 10.1099/00207713-49-4-1793
[35]
Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, et al. (2000) C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharmacol Rev 52: 91–112.
[36]
Nordstrom T, Blom AM, Forsgren A, Riesbeck K (2004) The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 173: 4598–4606.
[37]
Meri T, Blom AM, Hartmann A, Lenk D, Meri S, et al. (2004) The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect Immun 72: 6633–6641. doi: 10.1128/IAI.72.11.6633-6641.2004
[38]
Johnsson E, Thern A, Dahlback B, Heden LO, Wikstrom M, et al. (1996) A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP. J Immunol 157: 3021–3029.
[39]
Berggard K, Lindahl G, Dahlback B, Blom AM (2001) Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. Eur J Immunol 31: 2771–2780. doi: 10.1002/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0
[40]
Bartra SS, Styer KL, O'Bryant DM, Nilles ML, Hinnebusch BJ, et al. (2008) Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein. Infect Immun 76: 612–622. doi: 10.1128/IAI.01125-07
[41]
Thern A, Stenberg L, Dahlback B, Lindahl G (1995) Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol 154: 375–386.
[42]
Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, et al. (2001) Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med 193: 281–295. doi: 10.1084/jem.193.3.281
[43]
Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC (2002) A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. J Immunol 169: 6352–6360.
[44]
Blom AM, Zadura AF, Villoutreix BO, Dahlback B (2000) Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. Mol Immunol 37: 445–453. doi: 10.1016/S0161-5890(00)00059-6
[45]
Kirjavainen V, Jarva H, Biedzka-Sarek M, Blom AM, Skurnik M, et al. (2008) Yersinia enterocolitica serum resistance proteins YadA and ail bind the complement regulator C4b-binding protein. PLoS Pathog 4: e1000140. doi: 10.1371/journal.ppat.1000140
[46]
Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, et al. (2001) C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae. Int Immunopharmacol 1: 423–432. doi: 10.1016/S1567-5769(00)00037-0
[47]
Colombo MJ, Alugupalli KR (2008) Complement factor H-binding protein, a putative virulence determinant of Borrelia hermsii, is an antigenic target for protective B1b lymphocytes. J Immunol 180: 4858–4864.
[48]
Hovis KM, Schriefer ME, Bahlani S, Marconi RT (2006) Immunological and molecular analyses of the Borrelia hermsii factor H and factor H-like protein 1 binding protein, FhbA: demonstration of its utility as a diagnostic marker and epidemiological tool for tick-borne relapsing fever. Infect Immun 74: 4519–4529. doi: 10.1128/IAI.00377-06
[49]
Dahlback B, Stenflo J (1981) High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci U S A 78: 2512–2516. doi: 10.1073/pnas.78.4.2512
[50]
Schwalbe RA, Dahlback B, Nelsestuen GL (1990) Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes. J Biol Chem 265: 21749–21757.
[51]
Schwalbe R, Dahlback B, Hillarp A, Nelsestuen G (1990) Assembly of protein S and C4b-binding protein on membranes. J Biol Chem 265: 16074–16081.
[52]
Norman MU, Moriarty TJ, Dresser AR, Millen B, Kubes P, et al. (2008) Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog 4: e1000169. doi: 10.1371/journal.ppat.1000169
[53]
Larsson C, Lundqvist J, van Rooijen N, Bergstrom S (2009) A Novel Animal Model of Borrelia recurrentis Louse-Borne Relapsing Fever Borreliosis Using Immunodeficient Mice. PLoS Negl Trop Dis 3: e522. doi: 10.1371/journal.pntd.0000522
[54]
Ma YJ, Doni A, Hummelshoj T, Honore C, Bastone A, et al. (2009) Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem 284: 28263–28275. doi: 10.1074/jbc.M109.009225
[55]
Hulinska D, Volf P, Grubhoffer L (1992) Characterization of Borrelia burgdorferi glycoconjugates and surface carbohydrates. Zentralbl Bakteriol 276: 473–480. doi: 10.1016/S0934-8840(11)80672-9
[56]
Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R (2003) A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Proc Natl Acad Sci U S A 100: 7913–7918. doi: 10.1073/pnas.1232451100
[57]
Stubs G, Fingerle V, Wilske B, Gobel UB, Zahringer U, et al. (2009) Acylated cholesteryl galactosides are specific antigens of borrelia causing lyme disease and frequently induce antibodies in late stages of disease. J Biol Chem 284: 13326–13334. doi: 10.1074/jbc.M809575200
[58]
Vancova M, Nebesarova J, Grubhoffer L (2005) Lectin-binding characteristics of a Lyme borreliosis spirochete Borrelia burgdorferi sensu stricto. Folia Microbiol (Praha) 50: 229–238. doi: 10.1007/BF02931571
